Commerce Bank Bristol Myers Squibb CO Transaction History

Commerce Bank

$16.1 Billion
Q3 2024

A detailed history of Commerce Bank transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Commerce Bank holds 318,512 shares of BMY stock, worth $18.6 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

318,512

Previous 348,753 8.67%

Holding current value

$18.6 Million

Previous $14.5 Million 13.8%

% of portfolio

0.1%

Previous 0.09%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$39.66 - $51.75 $1.2 Million - $1.56 Million	-30,241 Reduced 8.67%	318,512 $16.5 Million
Q2 2024 Aug 12, 2024	SELL	$40.25 - $52.99 $7.16 Million - $9.43 Million	-177,979 Reduced 33.79%	348,753 $14.5 Million
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $16,313 - $18,496	340 Added 0.06%	526,732 $28.6 Million
Q4 2023 Feb 09, 2024	BUY	$48.48 - $57.85 $4.79 Million - $5.71 Million	98,784 Added 23.1%	526,392 $27 Million
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $3.34 Million - $3.73 Million	-57,646 Reduced 11.88%	427,608 $24.8 Million
Q2 2023 Aug 08, 2023	SELL	$63.71 - $70.74 $3.7 Million - $4.11 Million	-58,073 Reduced 10.69%	485,254 $31 Million
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $825,646 - $936,469	12,565 Added 2.37%	543,327 $37.7 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $6.45 Million - $7.64 Million	94,229 Added 21.59%	530,762 $38.2 Million
Q3 2022 Nov 04, 2022	BUY	$0.13 - $76.84 $938 - $554,938	7,222 Added 1.68%	436,533 $31 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $817,192 - $900,014	11,253 Added 2.69%	429,311 $33.1 Million
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $477,638 - $572,730	-7,769 Reduced 1.82%	418,058 $30.5 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $454,996 - $530,419	-8,484 Reduced 1.95%	425,827 $26.6 Million
Q3 2021 Nov 09, 2021	BUY	$59.17 - $69.31 $869,680 - $1.02 Million	14,698 Added 3.5%	434,311 $25.7 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $375,174 - $408,565	-6,060 Reduced 1.42%	419,613 $28 Million
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $627,342 - $705,575	10,572 Added 2.55%	425,673 $26.9 Million
Q4 2020 Feb 09, 2021	SELL	$57.74 - $65.43 $53,929 - $61,111	-934 Reduced 0.22%	415,101 $25.7 Million
Q3 2020 Nov 06, 2020	SELL	$57.43 - $63.64 $111,471 - $123,525	-1,941 Reduced 0.46%	416,035 $25.1 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $335,772 - $392,551	6,125 Added 1.49%	417,976 $24.6 Million
Q1 2020 May 08, 2020	SELL	$46.4 - $67.43 $79,065 - $114,900	-1,704 Reduced 0.41%	411,851 $23 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $6.29 Million - $8.2 Million	127,746 Added 44.7%	413,555 $26.5 Million
Q3 2019 Nov 12, 2019	SELL	$42.77 - $50.71 $39,562 - $46,906	-925 Reduced 0.32%	285,809 $14.5 Million
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $98,208 - $108,597	-2,201 Reduced 0.76%	286,734 $13 Million
Q1 2019 May 08, 2019	SELL	$45.12 - $53.8 $37,675 - $44,923	-835 Reduced 0.29%	288,935 $13.8 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $1.05 Million - $1.36 Million	-21,582 Reduced 6.93%	289,770 $15.1 Million
Q3 2018 Nov 02, 2018	SELL	$55.19 - $62.25 $574,693 - $648,209	-10,413 Reduced 3.24%	311,352 $19.3 Million
Q2 2018 Aug 08, 2018	SELL	$50.53 - $62.98 $160,331 - $199,835	-3,173 Reduced 0.98%	321,765 $17.8 Million
Q1 2018 May 03, 2018	SELL	$59.92 - $68.98 $91,198 - $104,987	-1,522 Reduced 0.47%	324,938 $20.6 Million
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $196,243 - $213,955	3,274 Added 1.01%	326,460 $20 Million
Q3 2017 Nov 07, 2017	SELL	$55.23 - $63.74 $22,312 - $25,750	-404 Reduced 0.12%	323,186 $18 Million
Q3 2017 Nov 07, 2017	BUY	$55.23 - $63.74 $17.9 Million - $20.6 Million	323,590	323,590 $20.6 Million

Others Institutions Holding BMY

# of Institutions

2,529

Shares Held

1.47B

Call Options Held

28M

Put Options Held

30.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account